Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2791683971;83972;83973 chr2:178562386;178562385;178562384chr2:179427113;179427112;179427111
N2AB2627579048;79049;79050 chr2:178562386;178562385;178562384chr2:179427113;179427112;179427111
N2A2534876267;76268;76269 chr2:178562386;178562385;178562384chr2:179427113;179427112;179427111
N2B1885156776;56777;56778 chr2:178562386;178562385;178562384chr2:179427113;179427112;179427111
Novex-11897657151;57152;57153 chr2:178562386;178562385;178562384chr2:179427113;179427112;179427111
Novex-21904357352;57353;57354 chr2:178562386;178562385;178562384chr2:179427113;179427112;179427111
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTT
  • RefSeq wild type template codon: CAA
  • Domain: Fn3-91
  • Domain position: 54
  • Structural Position: 77
  • Q(SASA): 0.2215
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/I None None 0.063 N 0.319 0.125 0.445410361449 gnomAD-2.1.1 3.18E-05 None None None None N None 0 0 None 0 0 None 0 None 0 6.48E-05 0
V/I None None 0.063 N 0.319 0.125 0.445410361449 gnomAD-4.0.0 2.05582E-06 None None None None N None 0 0 None 0 0 None 0 0 2.70027E-06 0 0
V/L rs770267115 -0.432 0.507 N 0.455 0.226 0.552125808554 gnomAD-2.1.1 4.06E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.95E-06 0
V/L rs770267115 -0.432 0.507 N 0.455 0.226 0.552125808554 gnomAD-4.0.0 6.85273E-07 None None None None N None 0 0 None 0 0 None 0 0 9.0009E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.288 likely_benign 0.2861 benign -1.366 Destabilizing 0.301 N 0.245 neutral N 0.521057747 None None N
V/C 0.7762 likely_pathogenic 0.7751 pathogenic -0.757 Destabilizing 1.0 D 0.622 neutral None None None None N
V/D 0.8046 likely_pathogenic 0.7964 pathogenic -1.154 Destabilizing 0.996 D 0.727 prob.delet. N 0.489976338 None None N
V/E 0.6692 likely_pathogenic 0.6763 pathogenic -1.048 Destabilizing 0.983 D 0.647 neutral None None None None N
V/F 0.4199 ambiguous 0.4236 ambiguous -0.817 Destabilizing 0.998 D 0.627 neutral N 0.476395214 None None N
V/G 0.2869 likely_benign 0.2973 benign -1.788 Destabilizing 0.991 D 0.676 prob.neutral N 0.50372278 None None N
V/H 0.8756 likely_pathogenic 0.8708 pathogenic -1.439 Destabilizing 1.0 D 0.747 deleterious None None None None N
V/I 0.1267 likely_benign 0.1355 benign -0.262 Destabilizing 0.063 N 0.319 neutral N 0.48823604 None None N
V/K 0.7859 likely_pathogenic 0.7995 pathogenic -0.906 Destabilizing 0.992 D 0.647 neutral None None None None N
V/L 0.4279 ambiguous 0.4613 ambiguous -0.262 Destabilizing 0.507 D 0.455 neutral N 0.471533369 None None N
V/M 0.2745 likely_benign 0.3035 benign -0.239 Destabilizing 0.998 D 0.545 neutral None None None None N
V/N 0.5779 likely_pathogenic 0.5731 pathogenic -0.885 Destabilizing 0.951 D 0.735 prob.delet. None None None None N
V/P 0.9585 likely_pathogenic 0.955 pathogenic -0.596 Destabilizing 0.975 D 0.696 prob.neutral None None None None N
V/Q 0.6718 likely_pathogenic 0.6634 pathogenic -0.885 Destabilizing 0.995 D 0.697 prob.neutral None None None None N
V/R 0.7795 likely_pathogenic 0.7833 pathogenic -0.67 Destabilizing 0.998 D 0.746 deleterious None None None None N
V/S 0.3309 likely_benign 0.3122 benign -1.506 Destabilizing 0.793 D 0.43 neutral None None None None N
V/T 0.2269 likely_benign 0.2449 benign -1.272 Destabilizing 0.896 D 0.47 neutral None None None None N
V/W 0.9648 likely_pathogenic 0.9648 pathogenic -1.174 Destabilizing 1.0 D 0.756 deleterious None None None None N
V/Y 0.8526 likely_pathogenic 0.8472 pathogenic -0.769 Destabilizing 0.999 D 0.633 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.